HIBRUKA Trademark

Trademark Overview


On Tuesday, October 26, 2021, a trademark application was filed for HIBRUKA with the United States Patent and Trademark Office. The USPTO has given the HIBRUKA trademark a serial number of 79329644. The federal status of this trademark filing is REGISTERED as of Tuesday, January 31, 2023. This trademark is owned by Beijing InnoCare Pharma Tech Co., Ltd.. The HIBRUKA trademark is filed in the Pharmaceutical Products category with the following description:

Medicines for the prevention and treatment of cancer and autoimmune diseases for human purposes; reagents for use in medical genetic testing; cultures of microorganisms for medical or veterinary use; vaccines; nutritional supplements; air purifying preparations; medicines for veterinary purposes for the prevention and treatment of cancer and autoimmune diseases; diagnostic preparations for medical purposes; preparations for destroying noxious animals; dietetic substances being foods and beverages adapted for the prevention and treatment of cancer and autoimmune diseases
hibruka

General Information


Serial Number79329644
Word MarkHIBRUKA
Filing DateTuesday, October 26, 2021
Status700 - REGISTERED
Status DateTuesday, January 31, 2023
Registration Number6966156
Registration DateTuesday, January 31, 2023
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 15, 2022

Trademark Statements


Description of MarkThe mark consists of the stylized wording "HIBRUKA" with a small geometric shape containing a smaller circle in its center in place of the dot in the letter "I".
Goods and ServicesMedicines for the prevention and treatment of cancer and autoimmune diseases for human purposes; reagents for use in medical genetic testing; cultures of microorganisms for medical or veterinary use; vaccines; nutritional supplements; air purifying preparations; medicines for veterinary purposes for the prevention and treatment of cancer and autoimmune diseases; diagnostic preparations for medical purposes; preparations for destroying noxious animals; dietetic substances being foods and beverages adapted for the prevention and treatment of cancer and autoimmune diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 12, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBeijing InnoCare Pharma Tech Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCN

Party NameBeijing InnoCare Pharma Tech Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCN

Party NameBeijing InnoCare Pharma Tech Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCN

Trademark Events


Event DateEvent Description
Tuesday, May 30, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, May 5, 2023FINAL DISPOSITION NOTICE SENT TO IB
Friday, May 5, 2023FINAL DISPOSITION PROCESSED
Sunday, April 30, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 31, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 31, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, November 15, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 15, 2022PUBLISHED FOR OPPOSITION
Wednesday, October 26, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 12, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 12, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, October 12, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, October 12, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, October 12, 2022EXAMINERS AMENDMENT -WRITTEN
Friday, October 7, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, October 7, 2022FINAL REFUSAL E-MAILED
Friday, October 7, 2022FINAL REFUSAL WRITTEN
Friday, September 9, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 9, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 9, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 5, 2022REFUSAL PROCESSED BY IB
Saturday, August 13, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, August 13, 2022REFUSAL PROCESSED BY MPU
Thursday, August 11, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, August 10, 2022NON-FINAL ACTION WRITTEN
Wednesday, August 3, 2022ASSIGNED TO EXAMINER
Friday, January 7, 2022APPLICATION FILING RECEIPT MAILED
Monday, January 3, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 30, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB